Heron Therapeutics Inc (HRTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRTX Giù? Forum Previsione Frazionamento azionario

Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1.28% 34.67	34.23	31.43	31.76	29.61
Cost Of Revenue	14.58% 8.444	9.885	18.21	20.16	16.85
Gross Profit	7.71% 26.23	24.35	13.23	11.60	12.76
Operating Expenses	10.25% 31.02	34.57	38.16	54.01	45.82
Benefits Costs and Expenses	10.25% 31.02	34.57	38.16	74.17	62.68
Costs And Expenses	10.25% 31.02	34.57	38.16	74.17	62.68
Operating Income/Loss	53.05% -4.798	-10.22	-24.93	-42.40	-33.06
Income/Loss From Continuing Operations Before Tax	1,188% 3.646	-0.335	-6.721	-42.06	-32.77
Income/Loss From Continuing Operations After Tax	70.53% -3.16	-10.72	-25.01	-42.06	-32.77
Net Income/Loss	70.53% -3.16	-10.72	-25.01	-42.06	-32.77
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,346% 151.20	4.388	144.99	119.72	119.25
Diluted Average Shares	3,346% 151.20	4.388	144.99	119.72	119.25
Basic Earnings Per Share	60.00% -0.02	-0.05	-0.17	-0.35	-0.27
Diluted Earnings Per Share	60.00% -0.02	-0.05	-0.17	-0.35	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$19.96

5.11%

INCY

$75.75

0.50%

UTHR

$376.80

0.74%

MRNA

$53.54

2.00%

BGNE

$207.25

1.49%

BNTX

$108.97

2.25%